Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US6162802 | SANDOZ | Synergistic combination therapy using benazepril and amlodipine for the treatment of cardiovascular disorders and compositions therefor |
Dec, 2017
(6 years ago) |
Market Authorisation Date: 03 March, 1995
Treatment: Method of treating hypertension
Dosage: CAPSULE;ORAL